The Gastroretentive Drug Delivery Systems Outsourcing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Dosage form (Tablets, Liquid, Microspheres, Capsule, Others), By Type (High Density System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, Floating Drug Delivery System, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies).
The Gastroretentive Drug Delivery Systems Outsourcing market in 2024 caters to the demand for contract manufacturing and outsourcing services for the development and production of gastroretentive drug delivery systems (GRDDS), specialized formulations designed to prolong gastric residence time and improve the bioavailability and therapeutic efficacy of oral medications for gastrointestinal and systemic diseases. Gastroretentive drug delivery systems include floating systems, mucoadhesive systems, expandable systems, and high-density systems that utilize various polymers, excipients, and formulation techniques to achieve gastric retention and controlled drug release profiles. Market dynamics are driven by factors such as the increasing demand for novel drug delivery technologies, advancements in polymer science and formulation engineering, and the outsourcing of pharmaceutical development and manufacturing activities by biopharmaceutical companies seeking expertise and cost-effective solutions. Collaboration between contract research organizations (CROs), pharmaceutical companies, and regulatory agencies drives innovation and market growth in gastroretentive drug delivery systems outsourcing, supporting accelerated drug development timelines and improved patient compliance and therapeutic outcomes.
A prominent trend in the gastroretentive drug delivery systems outsourcing market is the increasing demand for gastroretentive formulations. Gastroretentive drug delivery systems, designed to prolong the gastric residence time of pharmaceutical formulations, are gaining popularity due to their potential to improve the bioavailability, efficacy, and patient compliance of orally administered drugs. This trend is driven by the growing recognition of the benefits offered by gastroretentive systems, such as enhanced absorption of poorly soluble drugs, reduced dosing frequency, and targeted delivery to specific regions of the gastrointestinal tract. As pharmaceutical companies seek innovative solutions to overcome challenges associated with conventional drug delivery approaches, there is a rising need for outsourcing partners with expertise in developing and manufacturing gastroretentive formulations to meet market demands.
A key driver in the gastroretentive drug delivery systems outsourcing market is the expansion of contract research and manufacturing services. Pharmaceutical companies are increasingly outsourcing drug development and manufacturing activities to contract development and manufacturing organizations (CDMOs) to streamline operations, reduce costs, and access specialized expertise and capabilities. This trend is fueled by factors such as increasing complexity in drug development, regulatory requirements, and the need for flexible manufacturing capacity. With the growing demand for gastroretentive drug delivery systems, CDMOs offering expertise in formulation development, process optimization, and scale-up manufacturing of gastroretentive products are well-positioned to capitalize on market opportunities and support the outsourcing needs of pharmaceutical clients.
An opportunity for growth in the gastroretentive drug delivery systems outsourcing market lies in the development of customized formulations and technologies. As pharmaceutical companies seek differentiated products and competitive advantages in the market, there is a demand for outsourcing partners capable of developing tailored gastroretentive formulations that address specific drug delivery challenges and therapeutic requirements. By offering a comprehensive range of services, including formulation design, feasibility studies, prototype development, and technology transfer, outsourcing partners can collaborate closely with clients to design optimized gastroretentive drug delivery systems that meet their unique needs and accelerate the development timeline. This approach not only fosters innovation but also strengthens partnerships and enhances market competitiveness in the dynamic landscape of drug delivery outsourcing.
By Dosage Form
Tablets
Liquid
Microspheres
Capsule
Others
By Type
High Density System
Expandable Drug Delivery System
Bioadhesive Drug Delivery System
Floating Drug Delivery System
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Aenova Group
Aptar Pharma
Ashland
Catalent
Colorcon
Evonik
Evotec
Lonza
Quotient Sciences
Vectura Group Ltd
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Gastroretentive Drug Delivery Systems Outsourcing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Gastroretentive Drug Delivery Systems Outsourcing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Gastroretentive Drug Delivery Systems Outsourcing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Gastroretentive Drug Delivery Systems Outsourcing Market Size Outlook, $ Million, 2021 to 2030
3.2 Gastroretentive Drug Delivery Systems Outsourcing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Gastroretentive Drug Delivery Systems Outsourcing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Gastroretentive Drug Delivery Systems Outsourcing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Gastroretentive Drug Delivery Systems Outsourcing Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Gastroretentive Drug Delivery Systems Outsourcing Market Industry
4.2 Key Market Trends in Gastroretentive Drug Delivery Systems Outsourcing Market Industry
4.3 Potential Opportunities in Gastroretentive Drug Delivery Systems Outsourcing Market Industry
4.4 Key Challenges in Gastroretentive Drug Delivery Systems Outsourcing Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Gastroretentive Drug Delivery Systems Outsourcing Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Gastroretentive Drug Delivery Systems Outsourcing Market Outlook By Segments
7.1 Gastroretentive Drug Delivery Systems Outsourcing Market Outlook by Segments
By Dosage Form
Tablets
Liquid
Microspheres
Capsule
Others
By Type
High Density System
Expandable Drug Delivery System
Bioadhesive Drug Delivery System
Floating Drug Delivery System
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
8 North America Gastroretentive Drug Delivery Systems Outsourcing Market Analysis And Outlook To 2030
8.1 Introduction to North America Gastroretentive Drug Delivery Systems Outsourcing Markets in 2024
8.2 North America Gastroretentive Drug Delivery Systems Outsourcing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Gastroretentive Drug Delivery Systems Outsourcing Market size Outlook by Segments, 2021-2030
By Dosage Form
Tablets
Liquid
Microspheres
Capsule
Others
By Type
High Density System
Expandable Drug Delivery System
Bioadhesive Drug Delivery System
Floating Drug Delivery System
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
9 Europe Gastroretentive Drug Delivery Systems Outsourcing Market Analysis And Outlook To 2030
9.1 Introduction to Europe Gastroretentive Drug Delivery Systems Outsourcing Markets in 2024
9.2 Europe Gastroretentive Drug Delivery Systems Outsourcing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Gastroretentive Drug Delivery Systems Outsourcing Market Size Outlook By Segments, 2021-2030
By Dosage Form
Tablets
Liquid
Microspheres
Capsule
Others
By Type
High Density System
Expandable Drug Delivery System
Bioadhesive Drug Delivery System
Floating Drug Delivery System
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
10 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Markets in 2024
10.2 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market size Outlook by Segments, 2021-2030
By Dosage Form
Tablets
Liquid
Microspheres
Capsule
Others
By Type
High Density System
Expandable Drug Delivery System
Bioadhesive Drug Delivery System
Floating Drug Delivery System
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
11 South America Gastroretentive Drug Delivery Systems Outsourcing Market Analysis And Outlook To 2030
11.1 Introduction to South America Gastroretentive Drug Delivery Systems Outsourcing Markets in 2024
11.2 South America Gastroretentive Drug Delivery Systems Outsourcing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Gastroretentive Drug Delivery Systems Outsourcing Market size Outlook by Segments, 2021-2030
By Dosage Form
Tablets
Liquid
Microspheres
Capsule
Others
By Type
High Density System
Expandable Drug Delivery System
Bioadhesive Drug Delivery System
Floating Drug Delivery System
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
12 Middle East And Africa Gastroretentive Drug Delivery Systems Outsourcing Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Gastroretentive Drug Delivery Systems Outsourcing Markets in 2024
12.2 Middle East and Africa Gastroretentive Drug Delivery Systems Outsourcing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Gastroretentive Drug Delivery Systems Outsourcing Market size Outlook by Segments, 2021-2030
By Dosage Form
Tablets
Liquid
Microspheres
Capsule
Others
By Type
High Density System
Expandable Drug Delivery System
Bioadhesive Drug Delivery System
Floating Drug Delivery System
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Aenova Group
Aptar Pharma
Ashland
Catalent
Colorcon
Evonik
Evotec
Lonza
Quotient Sciences
Vectura Group Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Dosage Form
Tablets
Liquid
Microspheres
Capsule
Others
By Type
High Density System
Expandable Drug Delivery System
Bioadhesive Drug Delivery System
Floating Drug Delivery System
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The global Gastroretentive Drug Delivery Systems Outsourcing Market is one of the lucrative growth markets, poised to register a 7.3% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Aenova Group, Aptar Pharma, Ashland, Catalent, Colorcon, Evonik, Evotec, Lonza, Quotient Sciences, Vectura Group Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume